Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-10-04
1999-11-09
Celsa, Bennett
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 18, 514389, 530331, 564153, 564154, 5483014, 4241841, 4241851, A61K 3805, C07K 500
Patent
active
059814900
ABSTRACT:
Dipeptide compounds have therapeutic utility, inter alia, as metalloproteinase and TNF inhibitors.
REFERENCES:
Miller, R.B. et al. (1985) "Incorporation of Coordinating Amide Bond Surrogates within Mammalian Collagenase Inhibitors" Pept. Struct. Funct., Proc. Am. Pept. Symp., 9th:815-818.
Gray, R.D. et al. (1981) "Metal Binding Peptide Inhibitors of Vertebrate Collagenase" Biochemical and Biophysical Research Communication 101(4):1251-1258.
Fournie-Zaluski et al., Eur. J. Biochem 139 267-74(1984).
Spatola et al, "Chemistry & Biochemistry --Proteins" vol. 7 (Marcell Dekkes, 1983, Weinstein Ed) pp. 267-268, 338-340.
Baxter Andrew Douglas
Montana John Gary
Owen David Alan
Celsa Bennett
Darwin Discovery Ltd.
LandOfFree
Peptidyl compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptidyl compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptidyl compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456007